Chao Wu

Dr. Chao Wu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2023 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
QRQian-Wen Ren
Qian-Wen Ren
YWYan Wang
Yan Wang
JQJun Qian
Jun Qian
XZXiao-Xue Zhang
Xiao-Xue Zhang
YCYuan-Yuan Cheng
Yuan-Yuan Cheng
Chao WuChao Wu
Chao Wu

22 November 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
MXMin Xu
Min Xu
LYLei Yang
Lei Yang
YZYa-Wei Zhang
Ya-Wei Zhang
Chao WuChao Wu
Chao Wu
Yuanyuan ChengYuanyuan Cheng
Yuanyuan Cheng
HXHao Xue
Hao Xue
The increasing prevalence of antibiotic resistance necessitates the development of novel antimicrobial agents and therapeutic strategies. This study reports the extracellular biosynthesis of silver selenide nanoparticles (Ag2Se NPs) using Meyerozyma guilliermondii PG-1 and evaluates their antimicrobial and antibiofilm efficacy, both alone and in combination with gentamicin. The NPs were thoroughly characterized, confirming their nanoscale size, crystallinity, and biomolecule-mediated stability. Ag2Se NPs exhibited broad-spectrum antibacterial activity against Gram-positive (Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa, Escherichia coli) pathogens and showed strong synergy with gentamicin, particularly against P. aeruginosa and E. coli, as demonstrated through checkerboard and time–kill assays. The NPs also significantly inhibited biofilm formation and disrupted pre-formed biofilms. Mechanistic studies revealed that the antibacterial effects involved membrane disruption, ATP leakage, and elevated oxidative stress, while gene expression analysis in S. aureus indicated triggered stress responses related to biofilm formation. These findings suggest that biosynthesized Ag2Se NPs represent a promising synergistic agent for enhancing antibiotic efficacy and combating biofilm-related infections.